Loading insider details...
Beta
Latest Form 4 (Feb 12, 2026): Grant/Award of 3,461 PHAT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 12, 2026 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 3,461 | n/a |
| Jan 2, 2026 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 75,345 | n/a |
| Dec 19, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 17,370 | n/a |
| Jun 24, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 210,000 | n/a |
| Aug 7, 2024 | Sage Therapeutics, Inc. (SAGE) | Grant/Award | 13,500 | n/a |
| Feb 15, 2024 | Sage Therapeutics, Inc. (SAGE) | Grant/Award | 11,250 | n/a |